Grants and Contracts Details
HUMAN CLINICAL TRIAL - CONFIDENTIAL A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia in a Very High Risk Stratum STUDY: AALL1131 – SANOFI/GENZYME A study drug – Clofarabine (Ind #73789, NSC #606869) also known as Clolar® (US); clinical material as described further in the Protocol, which is a proprietary drug of the Funding Entity.
|Effective start/end date||9/23/15 → 10/10/19|
- Childrens Hospital of Philadelphia: $4,666.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.